Pharmacokinetic and Pharmacodynamic Interactions Between Metformin and a Novel Dipeptidyl Peptidase-4 Inhibitor, Evogliptin, in Healthy Subjects
Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s110712
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2016
Authors
Publisher
Informa UK Limited